首页 | 本学科首页   官方微博 | 高级检索  
     


Patient-reported outcomes of deferasirox (Exjade, ICL670) versus deferoxamine in sickle cell disease patients with transfusional hemosiderosis. Substudy of a randomized open-label phase II trial
Authors:Vichinsky Elliott  Pakbaz Zahra  Onyekwere Onyinye  Porter John  Swerdlow Paul  Coates Thomas  Lane Peter  Files Beatrice  Mueller Brigitta U  Coïc Lena  Forni Gian Luca  Fischer Roland  Marks Peter  Rofail Diana  Abetz Linda  Baladi Jean-Francois
Affiliation:Children's Hospital and Research Center, Oakland, CA 94609, USA. evichinsky@mail.cho.org
Abstract:
Keywords:
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号